Page last updated: 2024-11-12

cecropin b protein, insecta

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cecropin B protein, Insecta: from cecropia moth, Hyalophora cecropia; small basic protein; has potent antibacterial activity against E coli & other Gram-negative bacteria; also found in a variety of other insects; structure given in first source; also prevents development of malarial oocysts in mosquito vector [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Cecropiagenus[no description available]UrticaceaeThe nettles plant family of the order ROSALES, superorder ROSANAE, and class MAGNOLIOPSIDA. Many have stinging hairs on stems and leaves with flowers that are small and greenish in leaf axils. The fruit is dry and one-seeded.[MeSH]

Cross-References

ID SourceID
PubMed CID16130488
CHEMBL ID1673088
MeSH IDM0098107

Synonyms (10)

Synonym
cecropin b
cecropin b protein, insecta
p9b protein
CHEMBL1673088
cecropin b protein, hyalophora cecropia
p9b protein, insecta
p9b protein, hyalophora cecropia
EX-A7391
DTXSID90230334
cecropin b protein,insecta
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (24)

Assay IDTitleYearJournalArticle
AID573073Antimicrobial activity against Vibrio vulnificus assessed as reduced cell size at 70 ug/ml by SEM2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573058Antimicrobial activity against Vibrio vulnificus assessed as increase in bacterial survival at 100 ug/ml by broth culture growth inhibition assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573065Antimicrobial activity against Vibrio vulnificus selected after 70 ug/ml of drug exposure2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573076Antimicrobial activity against Vibrio anguillarum 775 assessed as reduction in extracellular product secreted by cells at 120 ug/ml2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573069Antimicrobial activity against compound-exposed Vibrio anguillarum 775 infected in CHSE-214 cells assessed as increase in adhesion to cells at 120 ug/ml after 60 mins relative to control2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573059Antimicrobial activity against Yersinia ruckeri assessed as increase in bacterial survival at 100 ug/ml by broth culture growth inhibition assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573067Antimicrobial activity against Pseudomonas fluorescens selected after 20 ug/ml of drug exposure2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573066Antimicrobial activity against Yersinia ruckeri selected after 90 ug/ml of drug exposure2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573063Antimicrobial activity against Pseudomonas fluorescens2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573072Antimicrobial activity against Yersinia ruckeri assessed as appearance of ridges on outer surface of the bacterial cell at 90 ug/ml by SEM2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573077Antimicrobial activity against Vibrio anguillarum 775 selected after passage with 120 ug/ml of compound2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573079Antimicrobial activity against Yersinia ruckeri selected after passage with 90 ug/ml of compound2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573071Antimicrobial activity against Vibrio anguillarum 775 infected in medaka fish assessed as mortality at 120 ug/ml by immersion challenge assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573070Antimicrobial activity against compound-exposed Vibrio anguillarum 775 infected in CHSE-214 cells assessed as increase in adhesion to cells at 120 ug/ml after 90 mins relative to control2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573062Antimicrobial activity against Yersinia ruckeri2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573061Antimicrobial activity against Vibrio vulnificus2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573068Antimicrobial activity against compound-exposed Vibrio anguillarum 775 infected in CHSE-214 cells assessed as increase in adhesion to cells at 120 ug/ml after 30 mins relative to control2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573078Antimicrobial activity against Vibrio vulnificus selected after passage with 70 ug/ml of compound2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573075Antimicrobial activity against Vibrio vulnificus assessed as appearance of rugose membrane shape at 70 ug/ml by SEM2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573064Antimicrobial activity against Vibrio anguillarum 775 selected after 120 ug/ml of drug exposure2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573080Antimicrobial activity against Pseudomonas fluorescens selected after passage with after 20 ug/ml of compound2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573074Antimicrobial activity against Vibrio vulnificus assessed as loss of flagella at 70 ug/ml by SEM2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573057Antimicrobial activity against Vibrio anguillarum 775 assessed as increase in bacterial survival at 100 ug/ml by broth culture growth inhibition assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
AID573060Antimicrobial activity against Vibrio anguillarum 7752008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Inducible resistance of fish bacterial pathogens to the antimicrobial peptide cecropin B.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (121)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (11.57)18.7374
1990's40 (33.06)18.2507
2000's37 (30.58)29.6817
2010's26 (21.49)24.3611
2020's4 (3.31)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.92 (24.57)
Research Supply Index4.84 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.80%)5.53%
Reviews4 (3.20%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other120 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]